Soren Acquisition Corp. completed its IPO of 25.3 million units, raising $253 million for potential healthcare industry acquisitions.
Quiver AI Summary
Soren Acquisition Corp. announced the completion of its initial public offering, closing on 25,300,000 units priced at $10.00 each, generating gross proceeds of $253 million. The units, which began trading on January 7, 2026, on the Nasdaq under the ticker symbol “SORNU,” consist of one Class A ordinary share and one-third of a redeemable warrant. The company, a blank check entity, plans to pursue business combinations, particularly in the healthcare sector. Led by CEO Arghavan Di Rezze and CFO Jamie Weber, Soren's management team aims to identify attractive acquisition opportunities. The offering was managed by BTIG, LLC, with legal counsel provided by several firms, and a registration statement was declared effective by the SEC prior to the offering.
Potential Positives
- Soren Acquisition Corp. successfully closed its initial public offering, raising gross proceeds of $253,000,000, which enhances its financial position for future growth and acquisition opportunities.
- The offering's successful pricing at $10.00 per unit is indicative of strong market interest and confidence in the Company's potential.
- The Company is now publicly traded on the Nasdaq under the ticker symbol “SORNU,” which increases its visibility and credibility in the market.
- Having a focused strategy on acquiring target businesses within the healthcare industry positions the Company well in a sector that has substantial growth potential.
Potential Negatives
- The company is a blank check company, which may raise concerns among investors regarding the uncertainty and risks associated with potential acquisitions.
- Forward-looking statements about the use of net proceeds and the search for a business combination come with no assurance, potentially signaling volatility in the company’s future plans.
- The emphasis on compliance with securities laws and the limitations on offers could indicate potential regulatory scrutiny or challenges ahead.
FAQ
What is the closing date of Soren Acquisition Corp's IPO?
The closing date of Soren Acquisition Corp's IPO was January 8, 2026.
How many units were offered in the IPO?
A total of 25,300,000 units were offered in the IPO, including 3,300,000 from the over-allotment option.
What is the trading symbol for Soren Acquisition Corp on Nasdaq?
The trading symbol for Soren Acquisition Corp on Nasdaq is "SORNU."
What will the Class A ordinary shares and warrants trade under?
The Class A ordinary shares and warrants will trade under the symbols "SORN" and "SORNW," respectively.
What industry is Soren Acquisition Corp focused on for acquisitions?
Soren Acquisition Corp is focused on making acquisitions in the healthcare industry.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
Full Release
Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.
The Company’s units began trading on January 7, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “SORNU.” Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “SORN” and “SORNW,” respectively.
The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.
The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as Advisors to the Company.
BTIG, LLC acted as sole book-running manager for the offering. Reed Smith LLP served as legal counsel to the Company and Walkers (Cayman) LLP served as Cayman Islands counsel to the Company. Ellenoff Grossman & Schole LLP served as legal counsel to the underwriter.
The offering was made only by means of a prospectus, copies of which may be obtained from: BTIG, LLC, 65 East 55th Street New York, New York 10022, or by email at [email protected].
A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on January 6, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds of the offering and the Company’s search for an initial business combination. No assurance can be given that the net proceeds of the offering will be used as indicated.
Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov . The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Investor Contacts
Soren Acquisition Corp.
Arghavan Di Rezze, Chief Executive Officer
[email protected]
